Currently, approximately 40% of familial breast cancer risk is explained by a combination of common low-penetrance variants [2,3], together with coding rarer variants in predisposition genes, such as BRCA1, BRCA2, PALB2, ATM, and CHEK2 that confer higher risks [4]. Here, CHEK2 is linked to breast carcinoma.